Shanghai HeartCare Medical Technology (HKSE:06609) DeferredTaxAndRevenue: HK$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
80 GF Score
Price HK$45.92
GF Value HK$54.97
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Shanghai HeartCare Medical Technology DeferredTaxAndRevenue?

Shanghai HeartCare Medical Technology HKSE:06609 -2.26% 80 DeferredTaxAndRevenue is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:06609 with a GF Score™ of 80/100 and a GF Value™ of HK$54.97 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Shanghai HeartCare Medical Technology's current deferred tax and revenue for the quarter that ended in Dec. 2025 was HK$0.0 Mil.

Shanghai HeartCare Medical Technology DeferredTaxAndRevenue Related Terms

Shanghai HeartCare Medical Technology DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology DeferredTaxAndRevenue Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:06609
80GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of HK$0.0 Mil mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a DeferredTaxAndRevenue of HK$0.0 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shanghai HeartCare Medical Technology.
Is Shanghai HeartCare Medical Technology's DeferredTaxAndRevenue too high?
Shanghai HeartCare Medical Technology's current DeferredTaxAndRevenue is HK$0.0 Mil. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's DeferredTaxAndRevenue compare to ABT and SYK?
Shanghai HeartCare Medical Technology's DeferredTaxAndRevenue of HK$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shanghai HeartCare Medical Technology. Shanghai HeartCare Medical Technology's current DeferredTaxAndRevenue is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.97, compared to a current price of HK$45.92 — trading 16.5% below its estimated fair value. The current DeferredTaxAndRevenue is HK$0.0 Mil. Shanghai HeartCare Medical Technology's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current DeferredTaxAndRevenue is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$45.92 is trading 16.5% below its estimated GF Value™ of HK$54.97. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • DeferredTaxAndRevenue: HK$0.0 Mil
  • GF Value™: HK$54.97 vs. price of HK$45.92 (16.5% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
80GF Score

Get the complete analysis for HKSE:06609

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$45.92
Price
HK$54.97
GF Value